Explore Our Medical Guides
Expert insights, practical advice, and trusted information to help international patients navigate care in China.
Find the right guide for you
Browse by condition
Drug-resistant epilepsy: new therapies and clinical trials in China
About one in three people with epilepsy do not achieve seizure control with the first two appropriate medications. Drug-resistant epilepsy i…
Reporting of adverse events in clinical trials in China
Adverse event reporting is a legal obligation for investigators and a practical safeguard for patients. When a patient returns home mid-tria…
Phase 0–IV Clinical Trial: Guidelines for Chinese Patients
Clinical trials are grouped into phases, and the phase tells you what the study is designed to answer. Confusing a phase I safety study with…
Clinical Trial Enrollment in China: Detailed Explanation of Screening
Screening is where most trial candidates are lost, and usually for reasons that were foreseeable. Understanding what the screen actually che…
Clinical Trial Costs in China: Itinerary and Follow-up
Trial participation is rarely free, even when the investigational drug is. Understanding which costs the sponsor covers and which fall to th…
Cell Therapy in China: Production and Quality Inspection
When a cell therapy product is prepared from a patient's own cells, quality is not an abstract property of the hospital — it depends on the …
Cell and Gene Therapy in China: Long-term Follow-up
Cell and gene therapies are given once and then followed for years. That follow-up is not administrative: integration into the genome, persi…
Cancer Vaccine Clinical Trials in China: Evidence and Enrollment Conditions
Cancer vaccines are among the most frequently misrepresented categories in medical travel enquiries. Patients hear "vaccine" and expect prev…
Bispecific Antibodies in China: Dose, Accessibility and Risk
Bispecific antibodies redirect T cells toward a tumour target by binding two antigens at once. Several are approved internationally and a gr…
Aplastic Anemia Drugs and Clinical Trials: Verifying Access in China
Aplastic anaemia is rare enough that treatment decisions are usually made in a small number of centres, and the choice between immunosuppres…
Drugs and Clinical Trials in Alzheimer's Disease: Accessibility and Evidence in China
Alzheimer's disease is the area where families most often ask about "new drugs in China" — and where the gap between what is approved, what …
After Completion of Clinical Trial in China: Follow-up Acquisition and Follow-up
Leaving a clinical trial is not the end of the medical relationship. Whether a patient completes the protocol, withdraws, or the trial close…
